+9,423.5%
STX vs GSK
+316.9%
+9,106.6%
-88.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | -0.6% | -0.3% | -0.6% |
| 7D | -17.3% | +5.2% | -22.5% | -19.1% |
| 30D | -35.9% | +10.2% | -46.1% | -38.9% |
| 3M | -37.3% | -0.9% | -36.4% | -37.9% |
| 6M | -35.8% | +3.5% | -39.3% | -38.6% |
| YTD | +82.7% | +7.2% | +75.5% | +70.3% |
| 1Y | +71.6% | +12.0% | +59.6% | +56.5% |
| 3Y | +635.3% | +67.3% | +567.9% | +428.7% |
| 5Y | +483.8% | +45.3% | +438.5% | +340.4% |
| 10Y | +1,967.8% | +101.8% | +1,866.0% | +1,170.5% |
| All | +9,423.5% | +316.9% | +9,106.6% | +4,033.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling